Lexaria’s DehydraTECH™ technology is covered by a robust suite of issued and pending patents in many countries around the world. Lexaria`s patent suite commenced with two initial 2014 US provisional patent applications. Since then, Lexaria has broadened the patent suite considerably.

In addition to US patent filings, Lexaria has also pursued international patent protection through filings under the Patent Cooperation Treaty, followed by national filings in multiple jurisdictions that are considered to have the highest commercial potential. Lexaria has 46 patents granted for its DehydraTECH technology in the US, Australia and the European Union, Japan, Mexico, Canada and India with expectations of additional patents to be granted, and many more additional patents pending. Links to the United States Patent and Trademark Office and the IP Australia websites are provided for your convenience, below. To see our patent portfolio, please conduct your searches using the keyword “Poviva” as our patents are held by our wholly owned subsidiary, Poviva Corp.